Physiotherapist as an alternative to a GP for musculoskeletal conditions: a 2-year service evaluation of UK primary care data

Por Downie, Fiona, McRitchie, Catherine, Monteith, Wendy, Turner, Helen
Publicado no Br J Gen Pract (2019)

Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP(2) Receptor Antagonist for Treatment of Asthma

Por Sandham, David A., Barker, Lucy, Brown, Lyndon, Brown, Zarin, Budd, David, Charlton, Steven J., Chatterjee, Devnandan, Cox, Brian, Dubois, Gerald, Duggan, Nicholas, Hall, Edward, Hatto, Julia, Maas, Janet, Manini, Jodie, Profit, Rachael, Riddy, Darren, Ritchie, Catherine, Sohal, Bindi, Shaw, Duncan, Stringer, Rowan, Sykes, David A., Thomas, Matthew, Turner, Katharine L., Watson, Simon J., West, Ryan, Willard, Elisabeth, Williams, Gareth, Willis, Jennifer
Publicado no ACS Med Chem Lett (2017)

Correction to “Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP(2) Receptor Antagonist for Treatment of Asthma”

Por Sandham, David A., Barker, Lucy, Brown, Lyndon, Brown, Zarin, Budd, David, Charlton, Steven J., Chatterjee, Devnandan, Cox, Brian, Dubois, Gerald, Duggan, Nicholas, Hall, Edward, Hatto, Julia, Leblanc, Catherine, Maas, Janet, Manini, Jodie, Profit, Rachael, Riddy, Darren, Ritchie, Catherine, Sohal, Bindi, Shaw, Duncan, Stringer, Rowan, Sykes, David A., Thomas, Matthew, Turner, Katharine L., Watson, Simon J., West, Ryan, Willard, Elisabeth, Williams, Gareth, Willis, Jennifer
Publicado no ACS Med Chem Lett (2017)